Benzinga | Aug 12, 2021 04:38PM EDT

Biolase Q2 EPS $0.00, Sales $9.10M Beat $8.31M Estimate

Biolase (NASDAQ:BIOL) reported quarterly sales of $9.10 million which beat the analyst consensus estimate of $8.31 million by 9.51 percent. This is a 209.73 percent increase over sales of $2.94 million the same period last year.